Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Translational therapy in patients with osteogenesis imperfecta - Denosumab pilot trial
DRKS00004521Phase 2Active, not recruiting
- Sponsor
- Children's University Hospital Cologne
- Start
- Feb 2013
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, single-arm trial of denosumab in osteogenesis imperfecta (OI), sponsored by Children's University Hospital Cologne. Started Feb 2013; status: active, not recruiting.
02
Drugs
denosumab
03
Conditions
osteogenesis imperfecta (OI)
Beyond the preview
Go deeper on DRKS00004521.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00004521.